Clik here to view.
Take the Red Tie Challenge for Bleeding Disorders Awareness Month!
NHF launches the Red Tie Challenge at Washington Days. Get your red on by joining the movement, and inviting your social media network.Read more about Take the Red Tie Challenge for Bleeding Disorders...
View ArticleClik here to view.
Join NHF's Thunderclap!
Help us spread awareness of bleeding disorders to a million people around the world.Read more about Join NHF's Thunderclap!
View ArticleClik here to view.
Teaching Children about Bleeding Disorders in NHF’s Nurses’ Guide
Information in this handy guide is broken down into age groups to help nurses educate and inform the children they treat.Read more about Teaching Children about Bleeding Disorders in NHF’s Nurses’ Guide
View ArticleClik here to view.
NHF and Believe Limited Join Forces
The new collaboration will create digital content and live events for people in the bleeding disorders community.Read more about NHF and Believe Limited Join Forces
View ArticleClik here to view.
FDA Approves Generic Version of Tranexamic Acid
New agent will provide another option for promoting blood clotting in patients with bleeding disorders undergoing dental procedures.Read more about FDA Approves Generic Version of Tranexamic Acid
View ArticleClik here to view.
MASAC Update on SIPPET
MASAC awaits full report before it considers revising its previous recommendation.Read more about MASAC Update on SIPPET
View ArticleClik here to view.
FDA Approves New Recombinant Factor IX Therapy for Hemophilia B
CSL Behring's Idelvion® stays in the bloodstream longer, potentially leading to fewer infusions.Read more about FDA Approves New Recombinant Factor IX Therapy for Hemophilia B
View ArticleClik here to view.
NHF CEO's Bleeding Disorders Awareness Month blog post featured on Huffington...
Inspirational account of overcoming great obstacles concludes by urging everyone to take the Red Tie Challenge during Bleeding Disorders Awareness Month.Read more about NHF CEO's Bleeding Disorders...
View ArticleFDA Approves Bayer’s Recombinant Factor VIII Therapy
The U.S. Food and Drug Administration recently approved KOVALTRY®, a recombinant factor FVIII therapy manufactured by Bayer. The product is indicated for the treatment and control of bleeding in adults...
View ArticleStudy of 50 Years of Hemophilia Healthcare Outcomes Yields Surprises
Results from a new study indicate that despite 50 years’ worth of advances in the area of comprehensive care for patients with bleeding disorders, males with hemophilia still grapple with significant...
View ArticleWomen Leaders in Hematology Featured in New Article
The American Journal of Hematology highlights the careers of female physicians who are movers and shakers in the community.Read more about Women Leaders in Hematology Featured in New Article
View ArticleClik here to view.
Three New MASAC Documents Available
The National Hemophilia Foundation’s (NHF's) Medical and Scientific Advisory Council (MASAC) issued the following three new documents, which were adopted by NHF’s Board of Directors on February 28,...
View ArticleClik here to view.
Digital Hemophilia Treatment Center Monitoring Linked to Significant...
Scientists from the Indiana HTC and MicroHealth present the results of a 12-month study on the effect of HTC digital monitoring on annual bleeding rates.Read more about Digital Hemophilia Treatment...
View ArticleClik here to view.
EMA Reviews Recurrence of HBV, Liver Cancer in Patients Taking Antivirals
Patients with previous hepatitis B infection, cirrhosis or hepatocellular carcinoma need follow-up after treatment with direct-acting antivirals. Read more about EMA Reviews Recurrence of HBV, Liver...
View ArticleClik here to view.
Preliminary Clinical Trial Data Shows Progress for BioMarin’s Factor VIII...
BioMarin Pharmaceutical Inc. recently announced preliminary data from an ongoing Phase 1/2 clinical trial with BMN 270, the company’s investigational gene therapy for the treatment of individuals with...
View ArticleClik here to view.
CME/CPE Symposium for Specialty Pharmacy and Managed Care Professionals
Reserve your spot for NHF 2016 Pre-conference Symposium on Specialty Pharmacy and Managed Care’s Role in Comprehensive Care on July 21, 2016 from 1:45-5pm.Read more about CME/CPE Symposium for...
View ArticleClik here to view.
Live CME/CE Workshops for Hemophilia Providers and Social Workers
Reserve your spot for NHF 2016 Provider Workshops Program, Highlighting Key Payer Issues and Recommended Solutions on July 23, 2016 from 1-5pm.Read more about Live CME/CE Workshops for Hemophilia...
View ArticleClik here to view.
Support NHF Through Give Local NYC
Mark Tuesday, May 3rd as the day you will contribute to the cause to improve the lives of people with bleeding disorders in NYC.Read more about Support NHF Through Give Local NYC
View ArticleClik here to view.
Deadlines Looming for HTRS Research Awards
Eligible candidates pursuing hemostasis and/or thrombosis research should apply now for two research-related awards.Read more about Deadlines Looming for HTRS Research Awards
View Article